EKATERINA REZVIN: Open Payments
NPI 1568943058 · WAYNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 20 payments from 6 companies in 2025. Trend: 2023 $355 · 2024 $378 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 10 | $323 |
| Alkermes, Inc. | 1 | $127 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $77 |
| ABBVIE INC. | 4 | $65 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Stryker Corporation | 1 | $26 |
Products named: FANAPT, LYBALVI, CAPLYTA, VRAYLAR, SPRAVATO, VSP SYSTEM, VSP CRANIAL.
Industry payments across NJ — which companies pay providers there.
